Delivery Order SPE2DB20D3111-SPE2DB25FA7NE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.92 to AmerisourceBergen Drug Corp for MICARDIS HCT 40-12.5 mg tablets (30-count unit dose packaging), with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order for pharmaceutical supplies supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,163.02 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 40-12.5 mg tablets in unit dose packaging (30 count) on September 2, 2025, with completion expected by September 3, 2025. This contract was awarded on a non-competitive, firm fixed-price basis and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,044.82 to supply Micardis HCT 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,416.12 to AmerisourceBergen Drug Corp for MICARDIS HCT 40-12.5 mg tablets (30-count unit dose packages) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract has a ceiling value of $12,248.33 and was issued on October 23, 2025, with an ultimate completion date of October 24, 2025. The delivery order utilizes firm fixed-price terms and will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $2,118.82 to AmerisourceBergen Drug Corp for Micardis HCT 80-25 mg tablets (unit dose, 30-count packaging) with a firm fixed price structure. This contract, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,599.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Micardis HCT 40-12.5 mg tablet unit dose packs (30 count). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.51 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with an ultimate completion date of September 10, 2025. This competitive award, issued on September 9, 2025, utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,037.48 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $1,772.81 to AmerisourceBergen Drug Corp for Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with a completion deadline of September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA7NEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,357.90 to AmerisourceBergen Drug Corp for MICARDIS HCT 80-25 mg tablets (30-count unit dose packaging) on April 24, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 25, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated substantial federal procurement capability through competitive award of multiple delivery orders under its DLA contract vehicle. The company supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The modest value of this particular delivery order reflects the transactional nature of individual pulls against the larger indefinite delivery contract, which enables flexible medical supply procurement to meet ongoing military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/24/25 |